Janus Capital Strikes Deal With Dai-Ichi Amid Heavy Insider Trading
Janus Capital Group Inc. (NYSE:JNS), which has been working to reverse 12 quarters of investor redemptions, recently received support from the second-largest life insurance provider in Japan, sending the company's stocks higher.
This came as a number of company executives performed insider transactions, suggesting they may know something about the deal public investors don't.
According to Bloomberg, Dai-ichi Insurance Co. said it will buy as much as 20 percent stake in Janus, and that it plans to invest $2 billion into the company to help it grow in Japan. Following the announcement, the company's stock rose 10 percent to $8.46, the biggest gain since July 2010.
"We think this is an undervalued asset and it may be a chance to get in at a good time," said Macrae Sykes, a Rye analyst. Sykes currently has a buy recommendation on the stock, and says the company will likely use the new funds to create new products.
Michael Kim, an analyst with Sandler O’Neill & Partners LP in New York, said the deal does not change the fundamental core business, and that Janus is still "dealing with sizeable redemptions and performance is an issue."
Read Full Insider Report For:
JNS |
